Literature DB >> 19909529

Frontal skull craniotomy combined with moderate-dose radiotherapy effectively ameliorate a rare case of non-secretory, multiple myeloma with orbital involvement.

Hui-Ling Ko1, Ching-Lin Chen, Kwan-Hwa Chi.   

Abstract

BACKGROUND: Orbital infiltration in patients with multiple myeloma is a rare condition, with less than 50 cases reported in the medical literature. Most patients undergo conservative treatment because multiple myeloma is a disseminated systemic disease. CASE
PRESENTATION: A 43-year-old male subject with multiple myeloma and long-term survival presented with orbital involvement. The subject lacked the typical features and poor prognostic factors associated with multiple myeloma, such as renal failure, hypercalcemia, and paraprotein in the serum and urine. The orbital computed tomographic scan revealed the tumor encasing the optic nerve, but without prominent bony destruction. Therefore, a frontal skull craniotomy with an epidural entrance to the orbital space was performed, to completely extirpate the orbital mass. The surgical procedure was followed by moderate-dose radiation therapy. After 32 months of follow-up care, the subject is doing well with excellent local control.
CONCLUSION: Although the effectiveness and applicability of this approach remains to be determined, this case report demonstrates that accurate and early detection combined with local surgical treatment and appropriate radio/chemotherapy, can be applied to effectively extend an orbital multiple myeloma patient's life.

Entities:  

Mesh:

Year:  2009        PMID: 19909529      PMCID: PMC2785810          DOI: 10.1186/1477-7819-7-86

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  21 in total

1.  Orbital multiple myeloma: case report and review of computed tomography features.

Authors:  T V Ajithkumar; C Sivasankar; K Ramachandran
Journal:  Australas Radiol       Date:  2002-03

2.  Orbital involvement in multiple myeloma: first sign of insufficient chemotherapy.

Authors:  Ulrike B Kottler; Claus Cursiefen; Leonard M Holbach
Journal:  Ophthalmologica       Date:  2003 Jan-Feb       Impact factor: 3.250

3.  Case report: multiple myeloma presenting as bilateral orbital masses: CT and MR appearances.

Authors:  A Jackson; J Kwartz; J L Noble; M J Reagan
Journal:  Br J Radiol       Date:  1993-03       Impact factor: 3.039

Review 4.  Targeting signaling pathways in multiple myeloma.

Authors:  Cavallo Federica; Palumbo Antonio; Tricot Guido; Boccadoro Mario
Journal:  Curr Pharm Biotechnol       Date:  2006-12       Impact factor: 2.837

5.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

6.  Prognostic factors in multiple myeloma.

Authors:  R Alexanian; S Balcerzak; J D Bonnet; E A Gehan; A Haut; J S Hewlett; R W Monto
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

7.  Orbital involvement in multiple myeloma. A new angiographic presentation.

Authors:  H A Hamburger
Journal:  J Clin Neuroophthalmol       Date:  1984-03

8.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 9.  Primary optic nerve sheath meningioma: stereotactic fractionated radiation therapy as an emerging treatment of choice.

Authors:  Branislav Jeremic; Susanne Pitz
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

10.  MRI in multiple myeloma with orbital and dural invasion.

Authors:  Nermin Tuncbilek; Hakki Muammer Karakas; Ozerk Omur Okten; Ozden Vural
Journal:  Tumori       Date:  2005 May-Jun
View more
  1 in total

1.  Ophthalmic Manifestations of Hematopoietic Malignancy.

Authors:  Natsuyo Yoshida-Hata; Naomichi Katai; Toshiyuki Oshitari
Journal:  Case Rep Ophthalmol Med       Date:  2016-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.